These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8529521)

  • 1. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
    Kramer W; Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
    Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
    Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct photoaffinity labeling of the putative sulfonylurea receptor in rat beta-cell tumor membranes by [3H]glibenclamide.
    Kramer W; Oekonomopulos R; Pünter J; Summ HD
    FEBS Lett; 1988 Mar; 229(2):355-9. PubMed ID: 2831099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoaffinity labeling of the cerebral sulfonylurea receptor using a novel radioiodinated azidoglibenclamide analogue.
    Schwanstecher M; Löser S; Chudziak F; Bachmann C; Panten U
    J Neurochem; 1994 Aug; 63(2):698-708. PubMed ID: 8035194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitochondrial sulfonylurea receptor: identification and characterization.
    Szewczyk A; Wójcik G; Lobanov NA; Nałecz MJ
    Biochem Biophys Res Commun; 1997 Jan; 230(3):611-5. PubMed ID: 9015372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a 65 kDa sulfonylurea receptor in rat pancreatic zymogen granule membranes.
    Braun M; Anderie I; Thévenod F
    FEBS Lett; 1997 Jul; 411(2-3):255-9. PubMed ID: 9271216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
    Stephan D; Winkler M; Kühner P; Russ U; Quast U
    Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
    Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
    Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
    J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic and extrapancreatic sulfonylurea receptors.
    Panten U; Schwanstecher M; Schwanstecher C
    Horm Metab Res; 1992 Dec; 24(12):549-54. PubMed ID: 1478610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
    Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
    Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beta-cell response to oral hypoglycemic agents.
    Cook DL
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S81-9. PubMed ID: 8529522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM; Tucker SJ; Seino S; Ashcroft FM
    Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea receptors and mechanism of sulfonylurea action.
    Panten U; Schwanstecher M; Schwanstecher C
    Exp Clin Endocrinol Diabetes; 1996; 104(1):1-9. PubMed ID: 8750563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.
    Schwanstecher M; Brandt C; Behrends S; Schaupp U; Panten U
    Br J Pharmacol; 1992 Jun; 106(2):295-301. PubMed ID: 1393263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology of glimepiride].
    Satoh Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():147-51. PubMed ID: 9434459
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
    Schwanstecher M; Mnner K; Panten U
    Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.